Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1963 2
1965 1
1966 1
1968 2
1970 1
1971 1
1972 6
1973 2
1974 3
1975 6
1976 3
1977 4
1979 10
1980 3
1981 2
1982 2
1983 6
1984 9
1985 10
1986 15
1987 20
1988 12
1989 14
1990 22
1991 18
1992 8
1993 9
1994 15
1995 17
1996 23
1997 22
1998 15
1999 12
2000 15
2001 19
2002 28
2003 22
2004 26
2005 12
2006 28
2007 18
2008 18
2009 23
2010 18
2011 23
2012 29
2013 42
2014 26
2015 15
2016 15
2017 25
2018 32
2019 28
2020 25
2021 35
2022 44
2023 32
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

847 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. Among authors: ishibashi s. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Guidance for the diagnosis and treatment of hypolipidemia disorders.
Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ, Goldberg IJ, Granot E, Hegele RA, Ishibashi S, Karmally W, Levy E, Moulin P, Okazaki H, Poinsot P, Rader DJ, Takahashi M, Tarugi P, Traber MG, Di Filippo M, Peretti N. Bredefeld C, et al. Among authors: ishibashi s. J Clin Lipidol. 2022 Nov-Dec;16(6):797-812. doi: 10.1016/j.jacl.2022.08.009. Epub 2022 Sep 29. J Clin Lipidol. 2022. PMID: 36243606 Free article. Review.
Mondor's Disease.
Ito H, Ishibashi S, Kaburagi T. Ito H, et al. Among authors: ishibashi s. Intern Med. 2019 Jun 15;58(12):1805. doi: 10.2169/internalmedicine.2024-18. Epub 2019 Feb 25. Intern Med. 2019. PMID: 30799346 Free PMC article. No abstract available.
Familial hypercholesterolemia.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K, Harada-Shiba M, Arai H, Bujo H, Nohara A, Ohta T, Oikawa S, Okada T, Wakatsuki A. Teramoto T, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2014;21(1):6-10. doi: 10.5551/jat.20040. Epub 2013 Dec 10. J Atheroscler Thromb. 2014. PMID: 24335046 Free article. No abstract available.
Metabolic syndrome.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2014;21(1):1-5. doi: 10.5551/jat.18473. Epub 2013 Dec 10. J Atheroscler Thromb. 2014. PMID: 24335036 Free article. No abstract available.
Current Diagnosis and Management of Abetalipoproteinemia.
Takahashi M, Okazaki H, Ohashi K, Ogura M, Ishibashi S, Okazaki S, Hirayama S, Hori M, Matsuki K, Yokoyama S, Harada-Shiba M. Takahashi M, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2021 Oct 1;28(10):1009-1019. doi: 10.5551/jat.RV17056. Epub 2021 May 16. J Atheroscler Thromb. 2021. PMID: 33994405 Free PMC article. Review.
Statements.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society Committee for Epidemiology and Clinical Management of Atherosclerosis. Teramoto T, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2014;21(4):299-303. doi: 10.5551/jat.ed002. Epub 2014 Apr 12. J Atheroscler Thromb. 2014. PMID: 24727684 Free article. No abstract available.
[Helsinki Heart Study].
Sekiya M, Ishibashi S. Sekiya M, et al. Among authors: ishibashi s. Nihon Rinsho. 2001 Mar;59 Suppl 3:404-9. Nihon Rinsho. 2001. PMID: 11347103 Review. Japanese. No abstract available.
Chronic kidney disease.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2014;21(3):173-4. doi: 10.5551/jat.19588. Epub 2013 Dec 10. J Atheroscler Thromb. 2014. PMID: 24335041 Free article. No abstract available.
Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis.
Yamada N, Karasawa T, Ito J, Yamamuro D, Morimoto K, Nakamura T, Komada T, Baatarjav C, Saimoto Y, Jinnouchi Y, Watanabe K, Miura K, Yahagi N, Nakagawa K, Matsumura T, Yamada KI, Ishibashi S, Sata N, Conrad M, Takahashi M. Yamada N, et al. Among authors: ishibashi s. Nat Commun. 2024 Mar 12;15(1):2195. doi: 10.1038/s41467-024-46386-6. Nat Commun. 2024. PMID: 38472233 Free PMC article.
847 results